Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients.

Leonilde Bonfrate Domenica M Di Palo Giuseppe CelanoAdelin AlbertPaola Vitellio Maria De Angelis Marco Gobbetti Nicolas Vuilleumier

Published in: European journal of clinical investigation (2020)

The novel formulation of B. longum BB536 and L. rhamnosus HN001 with B6 vitamin improves symptoms and severity of disease, restores intestinal permeability and gut microbiota in IBS patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
growth factor
drug delivery
depressive symptoms
sleep quality